These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 9815919)
1. Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin. Debinski W; Obiri NI; Powers SK; Pastan I; Puri RK Clin Cancer Res; 1995 Nov; 1(11):1253-8. PubMed ID: 9815919 [TBL] [Abstract][Full Text] [Related]
2. Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells. Debinski W; Miner R; Leland P; Obiri NI; Puri RK J Biol Chem; 1996 Sep; 271(37):22428-33. PubMed ID: 8798406 [TBL] [Abstract][Full Text] [Related]
3. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR). Puri RK; Leland P; Obiri NI; Husain SR; Kreitman RJ; Haas GP; Pastan I; Debinski W Blood; 1996 May; 87(10):4333-9. PubMed ID: 8639793 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin. Joshi BH; Kawakami K; Leland P; Puri RK Clin Cancer Res; 2002 Jun; 8(6):1948-56. PubMed ID: 12060640 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi's sarcoma xenograft. Husain SR; Puri RK Blood; 2000 Jun; 95(11):3506-13. PubMed ID: 10828036 [TBL] [Abstract][Full Text] [Related]
6. A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4. Debinski W; Obiri NI; Pastan I; Puri RK J Biol Chem; 1995 Jul; 270(28):16775-80. PubMed ID: 7622490 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by Pseudomonas exotoxin coupled to interleukin-13 and -4. Kornmann M; Kleeff J; Debinski W; Korc M Anticancer Res; 1999; 19(1A):125-31. PubMed ID: 10226533 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-13 receptor as a unique target for anti-glioblastoma therapy. Husain SR; Joshi BH; Puri RK Int J Cancer; 2001 Apr; 92(2):168-75. PubMed ID: 11291041 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-13 receptors on human prostate carcinoma cell lines represent a novel target for a chimeric protein composed of IL-13 and a mutated form of Pseudomonas exotoxin. Maini A; Hillman G; Haas GP; Wang CY; Montecillo E; Hamzavi F; Pontes JE; Leland P; Pastan I; Debinski W; Puri RK J Urol; 1997 Sep; 158(3 Pt 1):948-53. PubMed ID: 9258124 [TBL] [Abstract][Full Text] [Related]
10. Cintredekin besudotox in treatment of malignant glioma. Mut M; Sherman JH; Shaffrey ME; Schiff D Expert Opin Biol Ther; 2008 Jun; 8(6):805-12. PubMed ID: 18476792 [TBL] [Abstract][Full Text] [Related]
12. Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein. Husain SR; Obiri NI; Gill P; Zheng T; Pastan I; Debinski W; Puri RK Clin Cancer Res; 1997 Feb; 3(2):151-6. PubMed ID: 9815666 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer. Kawakami K; Kawakami M; Joshi BH; Puri RK Cancer Res; 2001 Aug; 61(16):6194-200. PubMed ID: 11507072 [TBL] [Abstract][Full Text] [Related]
14. Analysis of target genes induced by IL-13 cytotoxin in human glioblastoma cells. Han J; Yang L; Puri RK J Neurooncol; 2005 Mar; 72(1):35-46. PubMed ID: 15803373 [TBL] [Abstract][Full Text] [Related]
15. Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo. Leland P; Taguchi J; Husain SR; Kreitman RJ; Pastan I; Puri RK Mol Med; 2000 Mar; 6(3):165-78. PubMed ID: 10965493 [TBL] [Abstract][Full Text] [Related]
16. Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma. Puri RK; Hoon DS; Leland P; Snoy P; Rand RW; Pastan I; Kreitman RJ Cancer Res; 1996 Dec; 56(24):5631-7. PubMed ID: 8971168 [TBL] [Abstract][Full Text] [Related]
17. Sensitization of cancer cells to interleukin 13-pseudomonas exotoxin-induced cell death by gene transfer of interleukin 13 receptor alpha chain. Kawakami K; Joshi BH; Puri RK Hum Gene Ther; 2000 Sep; 11(13):1829-35. PubMed ID: 10986556 [TBL] [Abstract][Full Text] [Related]
18. Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein. Puri RK; Leland P; Kreitman RJ; Pastan I Int J Cancer; 1994 Aug; 58(4):574-81. PubMed ID: 8056454 [TBL] [Abstract][Full Text] [Related]
19. Recombinant F(ab') C242-Pseudomonas exotoxin, but not the whole antibody-based immunotoxin, causes regression of a human colorectal tumor xenograft. Debinski W; Pastan I Clin Cancer Res; 1995 Sep; 1(9):1015-22. PubMed ID: 9816074 [TBL] [Abstract][Full Text] [Related]
20. A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell lines. Klimka A; Barth S; Drillich S; Wels W; van Snick J; Renauld JC; Tesch H; Bohlen H; Diehl V; Engert A Cytokines Mol Ther; 1996 Sep; 2(3):139-46. PubMed ID: 9384698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]